retatrutide making me feel sick side effects: What to know Retatrutide: Is It The Next

All medications carry risks, and these weight-loss drugs are no different

Innovent receives FDA Approval for IND application of oral GLP-1R agonist IBI3032 owenhaskins Aug 6, 2025 2 min read Innovent Biologics has announced the FDA has approved the investigational new drug (IND) application to initiate a Phase 1 clinical trial of IBI3032, the company's novel oral GLP-1R agonist

Free 15 Minute Health Consultation Conclusion SIBO treatment kills off bacteria in your small intestine

The differentiator is pathway-level genetic context on FTO, GLP1R, and MC4R variants, which large platforms like Ro and focused programs like Henry Meds do not offer with the medication

Prescriptions may go unfilled once patients realize that their insurance companies wont foot the bill

Many participants felt judged for using medication to lose weight